Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Pre-Clinical
Canopus BioPharma, Inc. Announces Positive Results From An In-Vitro Live Ebola Virus Study 12/19/2014 8:46:21 AM
PTC Therapeutics, Inc. (PTCT) Release: Translarna Granted Orphan Drug Designation In The U.S. And Europe For The Treatment Of Mucopolysaccharidosis I 12/19/2014 8:03:40 AM
Novogen Limited (NVGN) Announces Breakthrough Discovery In The Treatment Of Melanoma 12/16/2014 9:20:39 AM
Nuvilex (NVLX) Provides Shareholder Update On Cancer And Diabetes Programs 12/16/2014 7:58:24 AM
Vaccinex, Inc. Announces Publication Of Preclinical Studies With An Anti-SEMA4D Antibody In Animal Models Of Neuroinflammatory And Demyelinating Disease 12/12/2014 8:26:09 AM
Syros Pharmaceuticals Announces New Research Published On CDK7 In Lung And Pediatric Cancers 12/11/2014 8:09:17 AM
Enzyme Bio-Systems Ltd. Release: Preclinical Xenograft Studies Show Positive Results For Amooranin 12/11/2014 5:13:29 AM
Kadmon Corporation Presents Preclinical Data On KD025 In Chronic Graft-Versus-Host-Disease At American Society of Hematology Annual Meeting 12/10/2014 11:34:50 AM
Celator Pharmaceuticals, Inc. Presents Data On CPX-351 At The 56th American Society of Hematology Annual Meeting 12/10/2014 7:51:21 AM
NIH Publishes Results Of Preclinical Collaboration With ChromaDex, Inc. Showing Potential Benefit Of Nicotinamide Riboside 12/10/2014 7:29:42 AM
Epizyme (EPZM) First-In-Class PRMT5 Inhibitor Demonstrates In Vitro And In Vivo Activity In Models Of Mantle Cell Lymphoma 12/9/2014 11:02:55 AM
GlycoMimetics, Inc. (GLYC) Highlights Potential Therapeutic Benefits Of Its Novel E-Selectin Antagonist At 56th American Society of Hematology Annual Meeting 12/9/2014 11:14:02 AM
Fate Therapeutics (FATE) Highlights Effects Of Nutrient-Rich Media On Ex Vivo Programmed CD34+ Cells Sourced From Umbilical Cord Blood 12/9/2014 10:21:54 AM
Aptose Biosciences Presents APTO-253 Preclinical Data At 56th American Society of Hematology Annual Meeting 12/9/2014 8:31:12 AM
Geron Corporation (GERN) Announces Publication Of Preclinical Data On Imetelstat Activity In Acute Myelogenous Leukemia 12/8/2014 9:34:50 AM
1234567
//-->